
791OUpdated results of GETUG-12, a phase III trial of docetaxel-based chemotherapy in high-risk localized prostate cancer, with a 12-year follow-up
Fizazi, K, Carmel, A, Joly, F, Delva, R, Gravis, G, Rolland, F, Priou, F, Ferrero, J-M, Houede, N, Mourey, L, Theodore, C, Krakowski, I, Berdah, J-F, Baciuchka Palmaro, M, Laguerre, B, Flechon, A, RavVolume:
29
Langue:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy284
Date:
October, 2018
Fichier:
PDF, 95 KB
english, 2018